Advanced in Primary Immunodeficiency (PID)

Bruce C. Ritchie

Edmonton, AB, CA 
Advanced in Primary Immunodeficiency (PID)
Edmonton, AB, CA 
OverviewLocationsClinical Research

Overview

Bruce Ritchie practices in Edmonton, Canada. Mr. Ritchie is rated as an Advanced expert by MediFind in the treatment of Primary Immunodeficiency (PID). His top areas of expertise are Angioedema, Hereditary Angioedema, Hives, and Acute Hepatic Porphyria (AHP).

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 1 clinical trial in the study of Primary Immunodeficiency (PID).

Gender
Male

Locations

Edmonton, AB, Canada
Other Locations
AB, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Safety, Tolerability, and Patient Satisfaction of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment by Rapid Push in Patients With Primary or Secondary Immunodeficiency (PID or SID)
Safety, Tolerability, and Patient Satisfaction of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment by Rapid Push in Patients With Primary or Secondary Immunodeficiency (PID or SID)
Enrollment Status: Active_not_recruiting
Publish Date: January 28, 2025
Intervention Type: Drug
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Biological
Study Phase: Phase 3
Patient-Centred Care for Warfarin Management: A Pilot Study to Transition Care to High Risk Patients
Patient-Centred Care for Warfarin Management: A Pilot Study to Transition Care to High Risk Patients
Enrollment Status: Completed
Publish Date: May 27, 2022
Intervention Type: Other
Study Phase: Not Applicable
D-dimer Testing, Tailored to Clinical Pretest Probability, to Minimize Initial and Follow-up Ultrasound Imaging in Suspected Deep Vein Thrombosis: A Management Study
D-dimer Testing, Tailored to Clinical Pretest Probability, to Minimize Initial and Follow-up Ultrasound Imaging in Suspected Deep Vein Thrombosis: A Management Study
Enrollment Status: Completed
Publish Date: September 28, 2021
View 3 Less Clinical Trials

61 Total Publications

Disease control and disease activity in hereditary angioedema: two sides of the same coin?
Disease control and disease activity in hereditary angioedema: two sides of the same coin?
Journal: Frontiers in immunology
Published: May 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ritchie's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 8 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile